Indian Drug Review Triple I (IDR Triple I) is a unique format book that has been created for the Point of Formulary. This book eases drug information search with its triple index, making it user friendly. The triple index includes:
- i-Therapeutic Section Index that contains therapeutic classification with sub-section.
- i-Company Index that contains an alphabetic listing of companies with addresses, brands, and generics.
- i-Generic & Brand Index that contains an alphabetic listing of generics and brands with company names.
IDR Triple I is beneficial for doctors, pharmacists and pharmaceutical companies who desire B2B advertisement.
- Name of the Publisher: CIMS Medica India
- Publishing Periodicity: Bimonthly
- International Standard Serial Number (ISSN): 0971-8125
- No. of Pages: 424
- Publisher Language: English
Circulation
IDR is predominantly sold through the following 2 Channels: Book Dealers and Subscription.
More than 225,000 copies of IDR are sold annually. Around 70% of IDR is circulated in the B2B market and 30% to HCPs.
Potential customers for IDR subscription
- Pharma Companies
- PCD Franchises
- Wholesalers
- Distributors
- Stockists
- Undercutters
- Chemists and Druggists
- Medical Reps
- Pharma Associations